Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118557563 | 11855756 | 3 | F | 20151211 | 20160120 | 20151221 | 20160128 | EXP | IE-TAKEDA-2015MPI008464 | TAKEDA | 78.00 | YR | M | Y | 82.90000 | KG | 20160128 | CN | IE | IE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118557563 | 11855756 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | 2.5 MG, UNK | 84684 | 21602 | 2.5 | MG | INJECTION | ||||||
| 118557563 | 11855756 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | 0 | ||||||||||
| 118557563 | 11855756 | 3 | SS | MELPHALAN | MELPHALAN | 1 | Unknown | UNK | 0 | ||||||||||
| 118557563 | 11855756 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 118557563 | 11855756 | 5 | C | LERCANIDIPINE | LERCANIDIPINE | 1 | Unknown | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 118557563 | 11855756 | 6 | C | COMBIVENT | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | Unknown | 4 MG, QD | 0 | 4 | MG | QD | |||||||
| 118557563 | 11855756 | 7 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | 15 MG, QD | 0 | 15 | MG | QD | |||||||
| 118557563 | 11855756 | 8 | C | CARDURA | DOXAZOSIN MESYLATE | 1 | Unknown | 8 MG, QD | 0 | 8 | MG | QD | |||||||
| 118557563 | 11855756 | 9 | C | MYCOSTATIN | NYSTATIN | 1 | Unknown | 1 ML, QID | 0 | 1 | ML | QID | |||||||
| 118557563 | 11855756 | 10 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 118557563 | 11855756 | 11 | C | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Unknown | 500 MG, QD | 0 | 500 | MG | QD | |||||||
| 118557563 | 11855756 | 12 | C | AMARYLL | 2 | Unknown | 1 MG, QD | 0 | 1 | MG | QD | ||||||||
| 118557563 | 11855756 | 13 | C | MINOXIDIL. | MINOXIDIL | 1 | Unknown | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 118557563 | 11855756 | 14 | C | LABETALOL | LABETALOLLABETALOL HYDROCHLORIDE | 1 | Unknown | 400 MG, TID | 0 | 400 | MG | TID | |||||||
| 118557563 | 11855756 | 15 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 120 MG, QD | 0 | 120 | MG | QD | |||||||
| 118557563 | 11855756 | 16 | C | FEBUXOSTAT. | FEBUXOSTAT | 1 | Unknown | 40 MG, UNK | 0 | 40 | MG | ||||||||
| 118557563 | 11855756 | 17 | C | VALACICLOVIR | VALACYCLOVIR HYDROCHLORIDE | 1 | Unknown | 500 MG, QD | 0 | 500 | MG | QD | |||||||
| 118557563 | 11855756 | 18 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | Unknown | 8 MG, BID | U | 0 | 8 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118557563 | 11855756 | 1 | Plasma cell myeloma |
| 118557563 | 11855756 | 2 | Plasma cell myeloma |
| 118557563 | 11855756 | 3 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118557563 | 11855756 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118557563 | 11855756 | Contusion | |
| 118557563 | 11855756 | Device occlusion | |
| 118557563 | 11855756 | Haematuria | |
| 118557563 | 11855756 | Haemoglobin decreased | |
| 118557563 | 11855756 | Platelet count decreased | |
| 118557563 | 11855756 | Purpura | |
| 118557563 | 11855756 | Thrombosis in device |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118557563 | 11855756 | 1 | 20151123 | 0 |